With an estimated glomerular filtration rate of 27 mL/min/1.73 m², should I discontinue lisinopril and metformin and add a different antihypertensive medication?

Do Not Stop Lisinopril at GFR 27

With a GFR of 27 mL/min/1.73 m², you should continue lisinopril (unless specific contraindications develop) and stop metformin immediately. 1, 2, 3

Lisinopril Management at GFR 27

Continue RAAS Blockade

• KDIGO guidelines explicitly state: "Do not routinely discontinue [RAAS antagonists] in people with GFR < 30 ml/min/1.73 m² as they remain nephroprotective" 1
• ACE inhibitors like lisinopril provide kidney protection even at advanced CKD stages (G4: GFR 15-29)
• Recent evidence shows that continuing ACE-I/ARB therapy when eGFR falls below 30 is associated with lower mortality (HR 0.72) and reduced cardiovascular events compared to discontinuation 4

When to Consider Dose Reduction or Discontinuation

Only reduce or stop lisinopril if you develop:

• Symptomatic hypotension that persists despite management
• Uncontrolled hyperkalemia (>5.5-6.0 mEq/L) despite medical treatment
• Serum creatinine rise >30% within 4 weeks of starting or dose increase (suggests functional renal artery stenosis)
• Uremic symptoms requiring dialysis preparation 1, 5

Monitoring Requirements

• Check serum creatinine and potassium within 2-4 weeks after any dose change 5
• Monitor every 3-6 months at this GFR level
• Temporarily suspend during acute illness, dehydration, or before contrast procedures 1

Metformin: Stop Immediately

Metformin is contraindicated at GFR <30 mL/min/1.73 m² 2, 3

Clear FDA and Guideline Consensus

• FDA label: "Metformin is contraindicated in patients with an eGFR less than 30 mL/min/1.73 m²" 3
• KDIGO 2020: "Stop metformin; do not initiate metformin" when eGFR <30 2
• Risk of lactic acidosis increases significantly below this threshold (HR 1.97 at eGFR <30) 6

Why This Matters

• Metformin is renally excreted and accumulates when GFR <30
• At GFR 27, you're in CKD Stage 4 (G4), where metformin clearance is severely impaired
• Even though lactic acidosis is rare, the risk-benefit ratio becomes unfavorable at this level of kidney function 7, 8

Blood Pressure Management Strategy

Do Not Add Different BP Medication to Replace Lisinopril

The question implies replacing lisinopril with another agent—this is not recommended. Instead:

1. Keep lisinopril as your foundation for kidney protection 1, 5

2. Add additional agents if BP target not met:

   • Target: <130/80 mmHg using standardized office measurement 5
   • Add dihydropyridine calcium channel blocker (amlodipine, nifedipine) 5
   • Add thiazide-like diuretic if needed (though loop diuretics often more effective at GFR <30)
   • Consider beta-blocker if you have heart failure or coronary disease

3. Dose adjustment for lisinopril at GFR 27:

   • Start at lower doses if newly initiating
   • If already on therapy, current dose likely appropriate unless side effects develop
   • Lisinopril is dialyzable, so dose timing matters if approaching dialysis 9

Common Pitfall to Avoid

Do not stop ACE-I/ARB simply because creatinine rises slightly or GFR drops below 30. This outdated practice increases cardiovascular mortality. The kidney protection and cardiovascular benefits persist even at advanced CKD 1, 4.

Alternative Diabetes Medications at GFR 27

Since you must stop metformin, consider:

First Priority: SGLT2 Inhibitor

• Initiate dapagliflozin or canagliflozin even at GFR 27 2, 10, 11
• KDIGO 2022 updated threshold: start SGLT2i at eGFR ≥20 mL/min/1.73 m² 11
• Provides kidney protection, cardiovascular benefits, and can be continued until dialysis 2
• Dapagliflozin: 10 mg daily (can initiate at GFR 25-44) 10
• Canagliflozin: maximum 100 mg daily at this GFR 10

Second Priority: GLP-1 Receptor Agonist

• Dulaglutide, liraglutide, or semaglutide require no dose adjustment at GFR 27 10, 12, 2
• Provide cardiovascular protection and possible kidney benefits
• Avoid exenatide (contraindicated at GFR <30) 12

Other Options with Dose Adjustment

• DPP-4 inhibitors: Sitagliptin 25 mg daily, saxagliptin 2.5 mg daily, linagliptin (no adjustment) 10, 12
• Insulin: May need 25-50% dose reduction due to decreased renal clearance 12
• Sulfonylureas: Use glipizide cautiously (liver-metabolized); avoid glyburide 1, 7

Summary Algorithm

At GFR 27 mL/min/1.73 m²:

1. ✓ Continue lisinopril (monitor K+ and creatinine closely)
2. ✗ Stop metformin immediately
3. ✓ Start SGLT2 inhibitor (dapagliflozin 10 mg or canagliflozin 100 mg)
4. ✓ Add other BP medications if needed (don't replace lisinopril)
5. ✓ Consider GLP-1 RA if additional glucose control needed
6. ✓ Monitor eGFR every 3-6 months and adjust medications accordingly

The evidence strongly supports maintaining RAAS blockade for kidney and cardiovascular protection at your current GFR level, while metformin must be discontinued due to accumulation risk 1, 2, 11, 4.